Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brazier

Showing results (131-140 of 1,450) with videos related to

Pageof 145
Sort By:
Lancet (London, England)|April 21, 1990
Hormone replacement therapy for osteoporosisF A Pitt, J Brazier
Anaerobe|June 1, 1995
A rapid test for the presumptive identification of Clostridium perfringensJ S Brazier, V Hall
Medical Care|August 21, 2004
The estimation of a preference-based measure of health from the SF-12John E Brazier, Jennifer Roberts
Annales Pharmaceutiques Francaises|March 1, 1976
[Alkaloids of some indigenous Senecio. II. Identification and structures]S Ferry, J L Brazier
Metabolic Engineering|December 19, 2012
Metabolic engineering of the flavone-C-glycoside pathway using polyprotein technologyMelissa Brazier-Hicks, Robert Edwards
Journal of Medical Ethics|December 20, 2015
Not so new directions in the law of consent? Examining Montgomery v Lanarkshire Health BoardAnne Maree Farrell, Margaret Brazier
Expert Review of Anti-Infective Therapy|July 23, 2009
Therapeutic interventions ameliorating prion diseaseMarcus W Brazier, Vanessa A Wall, Barry W Brazier, et al.
The Science of the Total Environment|January 1, 1979
Endemic goitre, the factors controlling iodine deficiency in soilsS R Aston, P H Brazier
Pharmacoeconomics|July 12, 2021
Valuing SF-6Dv2 in Australia Using an International ProtocolBrendan Mulhern, Richard Norman, John Brazier
Health and Quality of Life Outcomes|May 10, 2003
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6DStephen J Walters, John E Brazier
Pageof 145

Showing results (131-140 of 1,450) with videos related to

Sort By:
Pageof 145
Lancet (London, England)|April 21, 1990
Hormone replacement therapy for osteoporosisF A Pitt, J Brazier
Anaerobe|June 1, 1995
A rapid test for the presumptive identification of Clostridium perfringensJ S Brazier, V Hall
Medical Care|August 21, 2004
The estimation of a preference-based measure of health from the SF-12John E Brazier, Jennifer Roberts
Annales Pharmaceutiques Francaises|March 1, 1976
[Alkaloids of some indigenous Senecio. II. Identification and structures]S Ferry, J L Brazier
Metabolic Engineering|December 19, 2012
Metabolic engineering of the flavone-C-glycoside pathway using polyprotein technologyMelissa Brazier-Hicks, Robert Edwards
Journal of Medical Ethics|December 20, 2015
Not so new directions in the law of consent? Examining Montgomery v Lanarkshire Health BoardAnne Maree Farrell, Margaret Brazier
Expert Review of Anti-Infective Therapy|July 23, 2009
Therapeutic interventions ameliorating prion diseaseMarcus W Brazier, Vanessa A Wall, Barry W Brazier, et al.
The Science of the Total Environment|January 1, 1979
Endemic goitre, the factors controlling iodine deficiency in soilsS R Aston, P H Brazier
Pharmacoeconomics|July 12, 2021
Valuing SF-6Dv2 in Australia Using an International ProtocolBrendan Mulhern, Richard Norman, John Brazier
Health and Quality of Life Outcomes|May 10, 2003
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6DStephen J Walters, John E Brazier
Pageof 145